Gelie Qite Pian (格列齐特片(Ⅱ))格列齐特片(Ⅱ)

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

No product-level labeled indications/safety are joined for this record.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

格列齐特是一种在国家药监局注册认定的药品。该药品含有格列齐特-89c9668d等成分。

该药品关联的活性成分包括:格列齐特gliclazide。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:山东方明药业集团股份有限公司Chinese legal name: 山东方明药业集团股份有限公司。

您可以探索含有相同成分的其他药品:格列齐特-89c9668d成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 格列齐特片(Ⅱ)) is a medicine registered with the national drug regulatory authority. It contains gliclazide as active ingredient(s).

Active ingredients associated with this product: 格列齐特gliclazide.

Manufacturers recorded for this product: 山东方明药业集团股份有限公司Chinese legal name: 山东方明药业集团股份有限公司.

Explore other medicines containing the same ingredient: 格列齐特 productsgliclazide products.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 格列齐特片(Ⅱ)Recorded Chinese name: 格列齐特片(Ⅱ)
  • 规格Specification: 80mg*30片80 mg × 30 tablets
  • 命名冲突:来源不一致,以下仅展示已记录字段,未裁定唯一英文名。Name conflict across sources; showing recorded fields only; no invented English name.

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 山东方明药业集团股份有限公司Chinese legal name: 山东方明药业集团股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20033678

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (BLOCKED)Package-insert database (more than 100,000 records) (BLOCKED)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.